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Background. Norovirus is the leading cause of community-acquired and nosocomial acute gastroenteritis. Routine testing for 
norovirus is seldom undertaken, and diagnosis is mainly based on presenting symptoms. This makes understanding the burden of 
medically attended norovirus-attributable gastroenteritis (MA-NGE) and targeting care and prevention strategies challenging.
Methods. We used linked population-based healthcare datasets (Clinical Practice Research Datalink General Practice OnLine 
Database linked with Hospital Episode Statistics Admitted Patient Care) to model the incidence of MA-NGE associated with pri-
mary care consultations or hospitalizations according to age groups in England in the period July 2007–June 2013.
Results. Mean annual incidence rates of MA-NGE were 4.9/1000 person-years and 0.7/1000 person-years for episodes involving 
primary care or hospitalizations, respectively. Incidence rates were highest in children aged <5 years: 34.0 consultations/1000 per-
son-years and 3.3 hospitalizations/1000 person-years. Medically attended norovirus-attributable gastroenteritis hospitalization rates 
were second highest in adults aged >65 years (1.7/1000 person-years).
Conclusions. In this particular study, the burden of MA-NGE estimated from healthcare datasets was higher than previously 
estimated in small cohort studies in England. Routinely collected primary care and hospitalization datasets are useful resources to 
estimate and monitor the burden of MA-NGE in a population over time.
Keywords. norovirus; gastroenteritis; electronic health records; Clinical Practice Research Datalink (CPRD); Hospital Episode 
Statistics (HES).
 
Norovirus is the leading cause of acute gastroenteritis worldwide, 
causing both community-acquired disease and healthcare-associ-
ated outbreaks. Incidence rates are higher in young children, and 
hospitalization is common in both the very young and old [1]. 
Globally, norovirus-attributable gastroenteritis is estimated to cost 
society $60.3 billion each year, of which 62% is borne by high-in-
come countries and 66% is related to illness in children aged 
<5 years [2]. In the United States, medical costs due to norovirus 
infection in children aged <5 years alone have been estimated to 
approach $300 million per year [3]. In a population-based lon-
gitudinal study in the United Kingdom, norovirus was found to 
be the most common cause of community-acquired infectious 
intestinal disease (IID), resulting in nearly 3 million annual cases 
[4] and ₤81 million annually in costs to patients and the health 
system, exceeding costs of Campylobacter and rotavirus combined 
(estimated costs of ₤50 and ₤25 million, respectively) [5].
Paradoxically, unless there is an institutional outbreak 
of gastroenteritis, testing for norovirus is rarely performed. 
Knowledge of the burden of medically attended norovirus-at-
tributable gastroenteritis (MA-NGE) is generated mainly 
through infrequently conducted prospective cohort studies. 
These studies are labor-intensive and costly and lack precision 
for individual pathogens due to the limitation on the size of 
the study population. Alternative investigative methods that 
are less expensive, can be conducted regularly, and cover lon-
ger study periods, thereby allowing researchers to account for 
the 2–4 yearly pandemic cycles seen for norovirus [6], should 
therefore be explored and considered to create more in-depth 
and temporal knowledge on the burden of MA-NGE.
The aim of this study was to use linked population-based health-
care datasets to assess the incidence of medically attended gastro-
enteritis (MA-AGE) and model the incidence of MA-NGE based on 
seasonal patterns of MA-AGE for unspecified causes [7, 8]. Using 
linked primary care and hospitalization datasets for England for the 
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period July 2007–June 2013, we estimated the burden of MA-AGE 
and MA-NGE associated with primary care or hospitalization for 
different age groups, according to calendar year and month.
METHODS
Data Sources
Data were extracted from the Clinical Practice Research Datalink 
General Practice Online Database (CRPD-GOLD), linked with 
the Hospital Episode Statistics Admitted Patient Care (HES 
APC) data. the Clinical Practice Research Datalink General 
Practice Online Database is a primary care dataset of compu-
terized general practice medical records in the United Kingdom, 
managed by the Department of Health [9]. Data collection into 
CPRD GOLD began in 1987, and it currently holds data on 8% 
of the UK population. Hospital Episode Statistics Admitted 
Patient Care data contain details of all admissions to or atten-
dances at English National Health Service (NHS) healthcare 
providers, including private patients treated in NHS hospitals 
and NHS hospital patients treated elsewhere (Northern Ireland, 
Scotland, and Wales). Information has been collected since 1989 
and includes >125 million inpatient, outpatient, and accident 
and emergency records each year [10]. Approximately 75% of 
English practices participate in the CPRD linkage scheme.
For this study, we used data collected during the 6-year 
period between July 2007 and June 2013, starting at a time since 
sensitive norovirus diagnostics were introduced in the United 
Kingdom until the introduction of the rotavirus vaccine in the 
national childhood immunization program in July 2013.
Ethical Considerations
Specific patient informed consent was not required for this study. 
The CPRD has been granted Multiple Research Ethics Committee 
approval (05/MRE04/87) for purely observational studies, with 
external data linkages, including HES APC data. The work of CPRD 
is also covered by National Information Governance Board-Ethics 
and Confidentiality Committee (ECC) approval ECC 5-05 (a) 2012.
Data linkage was carried out by NHS Digital, and anonymized 
data were provided to the study team following approval of study 
protocol (Independent Scientific Advisory Committee protocol 
16_063R) by the Medicines and Healthcare Products Regulatory 
Agency Independent Scientific Advisory Committee.
Case Definition
Using International Classification of Diseases (ICD)-10 codes 
and Read codes, MA-AGE events were extracted from the linked 
dataset (see Supplementary Data). Read codes are the standard 
clinical terminology system used in general practices in the 
United Kingdom since 1985. Events were included when any 
ICD-10 or Read code associated with a diagnosis relating to gas-
troenteritis, gastrointestinal infection, or gastrointestinal patho-
gen was recorded, regardless of the diagnostic position of the 
indication. Medically attended gastroenteritis–related events in 
the HES APC data were derived from patients’ discharge records 
(the HES APC dataset does not distinguish between ICD-10 
positions as primary cause of admission or secondary diagno-
sis), including primary and nonprimary reasons for admission 
and hospital-acquired infections. An MA-AGE episode was 
defined as at least 1 MA-AGE event with the lag time between 
a successive event not exceeding 14 days. Hence, a recurrence 
with a lag time of >14 days was considered a new MA-AGE epi-
sode. Any episode was only accounted for once and classified as 
primary care only or hospitalization based on the level of care 
required over the course of the episode: if an episode contained 
at least 1 MA-AGE event from HES APC Inpatient, it was clas-
sified as associated with hospitalization (and not counted under 
primary care even if the episode involved a primary care event).
Episodes were grouped into MA-AGE episodes unspecified 
cause (not otherwise specified [NOS]) or cause-specific epi-
sodes, with the latter being further categorized into norovirus, 
rotavirus, other viral cause, Clostridium difficile, other bacterial 
cause, or parasitic. When a specific virus or bacterium was not 
specified, the episode was classified as ‘NOS’.
Statistical Methods
Observed MA-AGE incidence rates per 1000 person-years and 
exact Poisson 95% confidence intervals (Cis) were calculated 
for the total population, as well as separately by sex, age group, 
and time (year, month).
Because only a small proportion of MA-AGE episodes are 
cause-specified, the proportion of norovirus-attributable MA-AGE 
was estimated using an indirect modeling method developed and 
published for US datasets, with minor adaptations [7, 8]. Briefly, 
the model assumes that among the episodes with unspecified 
cause, the number due to a specified pathogen or pathogen group 
in a given month is proportional to the number of episodes actually 
coded for that same pathogen in the month. By using regression 
models assuming a negative binomial distribution to account for 
overdispersion, the monthly number of unspecified episodes was 
modeled as a function of cause-specified episodes. Separate models 
were fitted for each age group x and health care setting y, and an 
identity link function was used, which allows for an additive inter-
pretation. Instead of assuming a constant population denominator 
as applied in the US studies, the denominator was adapted accord-
ing to changes in population sizes over time.
Hence, the expected number of episodes “not otherwise 
specified” is modeled as
E(N_NOSx,y,t) = (αx,y × ptx,t) + (β1x,y × N_CDIFFx,y,t) + (β2x,y × 
N_OTHER BACTERIALx,y,t) + (β3x,y × (N_ROTA<5,y,t / pt<5,t) × 
ptx,t) + (γx,y × t × ptx,t), with N representing “counts” of AGE epi-
sodes (E) due to causes “not otherwise specified” (NOS), C. dif-
ficile (CDIFF), other bacterial infections (OTHER BACTERIAL) 
or rotavirus (ROTA), for age group x, health care setting y, and 
month t. α represents the background episode rate not explained 
by infections due to one of the specified pathogen categories; β 
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represents specific causes; and γ represents a secular linear time 
trend adding to the background rate. Person-time (in days) for 
age group x during month t is expressed as ptx,t.
The interpretation of the background allows for other non-
identified causes but also captures partly the nonseasonal com-
ponent of the causes captured.
For rotavirus infections, information from children aged 
<5 year was used for all age groups due to lack of data in other 
age groups, multiplying the rate in the group of <5  years with 
the denominator in the respective age groups. The classifica-
tions “parasitic infections” and “other viral infections” were not 
included in the models due to insufficient data. Backward step-
wise regression was used; variables that were not significant at 
the 5% level or those with negative coefficients were removed (as 
these are implausible) for each age group x and healthcare setting 
y, separately.
Because norovirus disease is rarely laboratory confirmed out-
side of institutional outbreaks, norovirus-confirmed episodes 
were not included in the equation. Instead, norovirus-attrib-
utable MA-AGE episodes were estimated for each month by 
calculating the difference between observed cause-unspecified 
and model-predicted counts (ie, the model residuals rx,y,t = N_
NOSx,y,t - E(N_NOSx,y,t), assuming that any remaining season-
ality not otherwise captured in the model is due to norovirus). 
From these residuals the (negative) quantity ptx,t × min(rx,y,t/
ptx,t) was subtracted (while adding it to the background), 
assuming that there is a month in which there are no MA-NGE 
episodes. The minimum represents the seasonal (July to June) 
minimum norovirus rate based on the raw residuals (ie, without 
subtracting). Estimated MA-NGE episodes modeled from non-
specific episodes were then added to the few coded MA-NGE 
episodes to get the total number of MA-NGE episodes.
Confidence intervals were obtained by bootstrapping based 
on the Poisson distribution of means from the original data 
using 10 000 replicates. Because the residuals procedure led to 
a systematic overestimation of norovirus rates in the bootstrap 
replicates, the method was adapted by centering the distribution 
of the bootstrap estimates on the original estimate: 95% confi-
dence intervals of the total rates were obtained from the 2.5 and 
97.5 percentiles of the bootstrapped results minus the difference 
between the 50 percentiles of the bootstrapped results and the 
original results.
RESULTS
Demographics
The linked dataset contained records of 4 487 649 individuals, 
with 15.5% having a follow-up time of <1 year; 49.1% having a 
follow-up time of >1 but <6 years, and 35.4% having a complete 
follow-up time of 6  years. At the time of inclusion, 10.7% of 
the population was aged 0–4 years, 13.3% was aged 5–17 years, 
62.3% was aged 18–64  years, and 13.8% was aged >65  years. 
There were similar proportions of males (49.3%) and females 
(50.7%) in the dataset.
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Figure 1. Observed incidence of medically attended gastroenteritis per calendar month in the period July 2007–June 2013 in England. Abbreviations: CI, confidence 
interval; MA-AGE, medically attended gastroenteritis. 
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Incidence of Medically Attended Gastroenteritis According to Health 
Care, Season, Age, Sex, and Specified Cause
A total of 592 696 MA-AGE episodes were recorded in the 
period July 2007–June 2013, corresponding to a mean 
annual rate of 34.62 episodes per 1000 person years (95% 
CI, 34.54–34.71). Although incidence rates varied year by 
year (Figure 1), a pattern of 2 seasonal peaks was observed: 
a smaller one in October–November and a larger one in 
January–April.
Most episodes (84%; n  =  497 089 episodes) were associ-
ated with primary care consultations only. The mean annual 
incidence rate of MA-AGE associated with primary care 
was 29.04/1000 person-years (95% CI, 28.96–29.12), and 
the mean annual incidence rate of MA-AGE associated 
with hospitalization was 5.59/1000 person-years (95% CI, 
5.55–5.62).
Children aged <5  years and adults aged >65  years had the 
highest rates of MA-AGE associated with primary care (age 
0–4  years: 120.53/1000 person-years, 95% CI, 119.84–121.22; 
age >65: 37.31/1000 person-years, 95% CI, 37.09–37.53) or hos-
pitalization (age 0–4  year: 13.40/1000 person-years, 95% CI, 
13.17–13.63; age >65: 13.95/1000 person-years, 95% CI, 13.81–
14.08) compared with age groups 5–17  years or 18–64  years 
(Figure  2). Overall the incidence of MA-AGE was higher for 
females (38.01 /1000 person years; 95% CI, 37.88–38.15) than 
for males (31.19/1000 person years; 95% CI, 31.08–31.31), 
except in boys aged <18 years for whom the incidence of both 
primary care and hospitalization associated MA-AGE was 
higher than in girls.
A pathogen was specified for 17 825 (3%) of the MA-AGE 
episodes. The proportion of episodes with unknown infectious 
cause was higher for those associated with primary care (98.3%) 
than hospitalization (90.0%) (Table 1). Clostridium difficile was 
the most frequently identified pathogen in hospitalization-asso-
ciated episodes, and bacterial pathogens other than C. difficile 
were the most frequently identified specified cause in primary 
care–associated episodes. Norovirus and rotavirus were more 
often identified in MA-AGE episodes associated with hospital-
ization than with primary care.
Seasonal peaks of pathogen-specific MA-AGE episodes 
were observed in all age groups, except for C. difficile–related 
episodes, which were identified continuously throughout 
the year and predominantly in older, hospitalized patients 
(Figure 3). Seasonal peaks of rotavirus-associated MA-AGE 
were observed in children aged <5 years, the only age group 
with a recommendation to routinely test for rotavirus [11]. 
Seasonal peaks of MA-NGE were observed in the group 
aged >65 years.
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Figure 2. Observed incidence of medically attended gastroenteritis, overall or associated with primary health care or hospitalization, according to age groups and sex. 
Abbreviations: CI, confidence interval; MA-AGE, medically attended gastroenteritis. 
Table 1. Pathogen-Specified and Unspecified Acute Gastroenteritis Episodes Associated With Primary Care or Hospitalization
Primary care Hospitalization
No. All episodes, %
Pathogen- specified 
episodes, % No. All episodes, %
Pathogen- specified 
episodes, %
Total episodes 497 089 95 607
Cause unspecified 488 825 98.3 % 86 046 90.0%
Norovirus 181 <0.1% 2.2% 1088 1.1% 11.3%
Rotavirus 279 <0.1% 3.4% 834 0.9% 8.6%
Other viral 38 <0.1% 0.5% 68 <0.1% 0.7%
Clostridium difficile 1177 0.2% 14.2% 6004 6.3% 62.1%
Other bacterial 6598 1.3% 79.7% 1546 1.6% 16.0%
Parasitic 4 <0.1% <0.1% 121 0.1% 1.3%
A pathogen was specified for 8264 primary care–associated acute gastroenteritis (AGE) episodes, including 13 episodes for which 2 pathogens were identified, bringing the total number of 
identified pathogens to 8277. For hospitalization-associated AGE, a pathogen was specified for 9561 episodes, including 100 episodes with 2 identified pathogens, bringing the total number 
of identified pathogens to 9661.
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Modelled Incidence Rates of Medically Attended Norovirus- and 
Rotavirus-Attributable Gastroenteritis
Norovirus and rotavirus were identified as the main causes of 
MA-AGE in all age groups, in addition to “bacterial pathogens 
other than C. difficile” in the group aged 17–64 years (Figure 4). 
Medically attended rotavirus-attributable gastroenteritis 
(MA-RGE) occurred predominantly between January and 
May, and this was true for all age groups (Figure 5). Medically 
attended norovirus-attributable gastroenteritis occurred more 
continuously throughout the year, with indications of 2 peaks 
Table 1. Pathogen-Specified and Unspecified Acute Gastroenteritis Episodes Associated With Primary Care or Hospitalization
Primary care Hospitalization
No. All episodes, %
Pathogen- specified 
episodes, % No. All episodes, %
Pathogen- specified 
episodes, %
Total episodes 497 089 95 607
Cause unspecified 488 825 98.3 % 86 046 90.0%
Norovirus 181 <0.1% 2.2% 1088 1.1% 11.3%
Rotavirus 279 <0.1% 3.4% 834 0.9% 8.6%
Other viral 38 <0.1% 0.5% 68 <0.1% 0.7%
Clostridium difficile 1177 0.2% 14.2% 6004 6.3% 62.1%
Other bacterial 6598 1.3% 79.7% 1546 1.6% 16.0%
Parasitic 4 <0.1% <0.1% 121 0.1% 1.3%
A pathogen was specified for 8264 primary care–associated acute gastroenteritis (AGE) episodes, including 13 episodes for which 2 pathogens were identified, bringing the total number of 
identified pathogens to 8277. For hospitalization-associated AGE, a pathogen was specified for 9561 episodes, including 100 episodes with 2 identified pathogens, bringing the total number 
of identified pathogens to 9661.
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Figure 3. Observed temporal incidence of medically attended gastroenteritis, overall or associated with primary health care or hospitalization, according to age groups. 
Abbreviations: CI, confidence interval; MA-AGE, medically attended gastroenteritis. 
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occurring in the younger age groups (0–4 y and 5–17 y) during 
October–December and February–May.
The mean annual incidence of MA-NGE associated with pri-
mary care was estimated at 4.93/1000 person-years (Table  2). 
The highest rate of MA-NGE was in children aged <5 years, with 
mean annual incidence rates of 34.0/1000 person-years for epi-
sodes associated with primary care and 3.3/1000 person-years 
for episodes associated with hospitalization. The incidence rate 
of MA-NGE associated with hospitalization was second high-
est in adults aged >65  years. Apart from episodes associated 
with hospitalization in children aged 0–4 years, MA-NGE inci-
dence rates associated with primary care or hospitalization were 
higher than for MA-RGE.
DISCUSSION
Using linked data from the CPRD-GOLD and HES APC 
datasets, we were able to estimate age group–specific annual 
incidence rates of MA-NGE in England in the period July 2007–
June 2013, finding rates as high as 34.0 consultations/1000 
person-years and 3.3 hospitalizations/1000 person-years for 
norovirus-attributable gastroenteritis in children aged <5 years.
Previously, 2 prospective cohort studies have been con-
ducted in the United Kingdom estimating the burden of IID in 
the community and associated general practice care, covering 
the periods 1993–1996 (IID1) [12] and 2008–2009 (IID2) [4]. 
These IID cohort data enabled us to compare the results from 
our study with a more conventional approach. We found a mean 
annual incidence rate of primary care–associated MA-AGE 
of 28.8/1000 person-years in England between July 2007 and 
June 2013. This is comparable to the 25.3/1000 person-years 
estimated from the IID2 population cohort for the period April 
2008–August 2009 [4]. In both the IID2 and our study, inci-
dence rates were the highest for children aged <5 years, corre-
sponding to a mean rate of 120/1000 person-years in our study 
and 133/1000 person-years in the IID2 cohort study.
In our analysis of hospitalization-associated gastroenteritis, 
all discharge records that included a gastroenteritis indication 
were taken into account, irrespective of whether this was a 
primary or nonprimary reason for admission or a hospital-ac-
quired infection. A  similar approach was taken in an earlier 
study in the United States [7]. Compared with an incidence 
rate of 5.5/1000 person-years found in our study, the US study 
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Figure 4. Estimated temporal incidence of medically attended gastroenteritis, overall or associated with primary health care or hospitalization, according to age groups. 
Abbreviations: CI, confidence interval; MA-AGE, medically attended gastroenteritis. 
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reported a rate of 2.5/1000 person-years for the period 1996–
2007 [7]. A rise in incidence rates was observed in the US study 
during the study period; it is therefore possible that after 2007 
rates may have been higher and approaching the rate we found 
in England during 2007–2013. Together these studies confirm 
that routinely collected hospital discharge records are useful 
resources to assess the incidence of hospitalization-associated 
gastroenteritis.
The overall and age-specific rates of primary care-associ-
ated MA-NGE found in our models were comparable with rates 
reported in the US between 2001 and 2009 [8] but were nearly 
double of what was reported for the IID2 study [13]. However, the 
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Figure 5. Estimated incidence of medically attended gastroenteritis attributable to norovirus or rotavirus per calendar month for each year in the period July 2007–June 
2013 in England. Abbreviations: CI, confidence interval; MA-AGE, medically attended gastroenteritis; MA-NGE, medically attended norovirus-attributed gastroenteritis; 
MA-RGE, medically attended rotavirus-attributed gastroenteritis. 
Table 2. Modeled Mean Annual Incidence Rate of Medically Attended Gastroenteritis, Norovirus-Attributed Gastroenteritis, and Rotavirus-Attributable 
Gastroenteritis According to Medical Care Category and Age Groups
MA-AGE MA-NGE MA-RGE
Primary care Hospitalization Primary care Hospitalization Primary care Hospitalization
Incidence per 1000 person-years (95% CI) Incidence per 1000 person-years (95% CI) Incidence per 1000 person-years (95% CI)
Age group
0–4 y 120.53 (119.85–121.21) 13.41 (13.18–13.64) 34.00 (27.46–42.60) 3.30 (2.41–4.44) 23.79 (21.56–25.85) 5.60 (5.29–5.92)
5–17 y 17.22 (17.06–17.39) 1.71 (1.66–1.76) 5.43 (4.90–6.06) 0.40 (0.30–0.50) 1.55 (1.31–1.78) 0.14 (.10–.19)
18–64 y 20.93 (20.84–21.01) 3.36 (3.33–3.40) 2.42 (2.10–2.76) 0.26 (0.20–0.33) 0.48 (.10–0.64) 0.0008 (.0003–.0013)
≥65 y 37.31 (37.09–37.52) 13.97 (13.84–14.10) 3.87 (3.26–4.49) 1.69 (1.41–2.00) 0.80 (.09–1.08) 0.70 (.57–.83)
All 29.04 (28.96–29.12) 5.59 (5.56–5.63) 4.93 (4.45–5.49) 0.71 (.62–0.80) 2.03 (1.63–2.27) 0.47 (.44–.50)
Abbreviations: MA-AGE, medically attended gastroenteritis; MA-NGE, medically attended norovirus-attributed gastroenteritis; MA-RGE, medically attended rotovirus-attributed gastroenteritis.
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population burden of norovirus infection in the IID2 study was 
recently reported to be around 26% higher than reported origi-
nally when using a less stringent cutoff for the norovirus diagnos-
tic polymerase chain reaction that included asymptomatic carriage 
and subclinical disease [14]. It is not clear whether the same dif-
ference could apply to the estimation of primary-care associated 
MA-NGE in the IID2 study, and this might more closely resemble 
the findings of the modeling approach. Prospective cohort stud-
ies are associated with a number of difficulties that could result 
in under-reporting, as well as relatively small sample sizes [13]. 
Alternatively, our model may have overestimated MA-NGE rates 
by falsely attributing cases to norovirus. Because we did not have 
access to full medical charts, we could not validate the specificity 
of the codes. However, we expect that the modeling approach fil-
ters out most noninfectious cases of gastroenteritis.
In our model, children aged <5 years had the highest estimated 
rates for primary care–associated and hospitalization-associated 
MA-NGE. The same was found for primary care–associated 
MA-NGE in the IID2 study [13]. Adults aged >65  years had 
the second highest estimated rate of hospitalization-associated 
MA-NGE in our model. To our knowledge, only 1 other study has 
reported on hospitalization-associated MA-NGE in older adults 
in the United Kingdom; however, reported rates were considerably 
lower (10–43/100 000 person-years in the period 2000–2006 [15]) 
than in our study (169/100 000 person-years), most likely because 
the earlier study only took into account emergency admissions 
with gastroenteritis as a primary diagnosis.
When stratifying for sex, the incidence of MA-AGE was 
found to be 30%–40% higher in adult females than males, but 
10%–15% higher in boys than girls aged <18 years. The same was 
true for MA-RGE, but not for MA-NGE, for which rates were 
higher in females across all age groups (data not shown). Thus 
the observed sex effect could be partly explained by a generally 
higher healthcare usage of adult women than men [16], as well 
as a sex difference in susceptibility to specific pathogens [17].
Our models showed that, although MA-RGE predominantly 
occurred in children aged <5 years, MA-NGE was found across all 
age groups. Childhood rotavirus vaccination was introduced in the 
United Kingdom in July 2013, with early reports finding a rapid 
decline in rotavirus infections since then [18–20]. It can therefore 
be expected that after July 2013 relatively more hospitalization-as-
sociated gastroenteritis in the group aged <5 years will be attributa-
ble to norovirus than rotavirus. Indeed, a recent study reported that 
in the period 2014–2015, 44% of patients in a UK pediatric hospi-
tal positive for a gastrointestinal virus were positive for norovirus 
[21]. Our modeling approach, which used linked primary care and 
hospitalization datasets to estimate temporal age group–specific 
MA-NGE and MA-RGE incidence rates, would be a very suitable 
tool to assess the impact of rotavirus vaccine implementation and 
reassess the incidence of MA-NGE in future studies.
An important finding from our study is that linked routinely 
collected primary care and hospitalization datasets can be used to 
study temporal and subgroup-specific incidence rates of MA-AGE 
and, more important, can be used to estimate the burden attributa-
ble to main causative pathogens not routinely tested for, such as nor-
ovirus. This approach has a number of advantages above the more 
conventional prospective cohort studies. First, the analysis of popu-
lation-based healthcare datasets can be repeated frequently for rela-
tively low costs and provide updated “real-time” and temporal data. 
This can be particularly relevant to measure or predict the impact 
of prevention and intervention programs. By linking primary care 
data with hospitalization data, we were able to stratify by the type 
of healthcare provided, which generates information relevant when 
studying the economic burden of disease and health interventions. 
Furthermore, due to the large size of the population included in 
these datasets, incidence rates can be assessed for subgroups of spe-
cific interest—for example, age groups as done here, but ultimately 
also for risk groups with specific underlying conditions. The use of 
routinely collected electronic health data for infectious disease bur-
den assessment will be limited by the testing performed as routine. 
We overcame this limitation by modeling the seasonality of the 
pathogen of interest. To apply this modeling approach, seasonality 
is needed combined with a minimal level of testing for the pathogen 
of interest and for the other pathogens that are also seasonal. If test-
ing information is lacking for only 1 pathogen, as was the case in our 
dataset, the residuals approach can be used.
In summary, this is the first study using the UK CPRD-
GOLD primary care research dataset linked with England’s 
Hospital Episode Statistics inpatient dataset to estimate the 
incidence rates of MA-AGE and MA-NGE in England, thereby 
differentiating between primary care and hospitalizations. 
Although the infectious cause of MA-AGE is rarely specified 
in clinical records, we demonstrate here that incidence rates of 
MA-NGE can be estimated using routinely collected primary 
care and hospitalization datasets. Datasets such as the CRPD 
can thus provide a useful resource to estimate and monitor the 
burden of MA-NGE in a population and provide baseline data 
for considering the potential health and economic benefit of 
new interventions such as vaccines and potentially to measure 
the impact of their introduction.
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